Groundbreaking trial tests new hope for rare genetic disorder
Disease control
Recruiting now
This early-stage study is testing an experimental drug called HM15421/GC1134A in adults with Fabry disease, a rare genetic condition. Researchers want to see if the treatment is safe and if it can reduce harmful substances that build up in patients' bodies. The study will enroll …
Phase: PHASE1, PHASE2 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC